FDA Inspection 992916 — Orion Corporation, Orion Pharma
The FDA completed an inspection of Orion Corporation, Orion Pharma on November 3, 2016 in Turku. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 3, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Turku (Finland)